Multicenter Pharmacokinetic Study of Pembrolizumab for Non-Small Cell Lung Cancer in Older Adults Aged Over 75 Years

被引：0
|
作者：
Horinouchi, H. [1 ]
Ohe, Y. [1 ]
Yamanaka, Y. [2 ]
Kurata, T. [2 ]
Watanabe, K. [3 ]
Hosomi, Y. [3 ]
Nakahara, Y. [4 ]
Asao, T. [5 ]
Saeki, S. [6 ]
Tsubata, Y. [7 ]
Fujita, Y. [8 ]
Konishi, J. S. [9 ]
Mizugaki, H. [10 ]
Ohuchi, M. [11 ]
Yagishita, S. [11 ]
Hamada, A. [11 ]
机构：
[1] Natl Canc Ctr, Tokyo, Japan
[2] Kansai Med Univ Hosp, Osaka, Japan
[3] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan
[4] Kitasato Univ, Sch Med, Sagamihara, Kanagawa, Japan
[5] Juntendo Univ Hosp, Tokyo, Japan
[6] Kumamoto Univ Hosp, Kumamoto, Japan
[7] Shimane Univ, Fac Med, Matsue, Shimane, Japan
[8] Jikei Univ, Sch Med, Tokyo, Japan
[9] Hokkaido Univ, Fac Med, Sapporo, Hokkaido, Japan
[10] JFCR, Canc Inst Hosp, Tokyo, Japan
[11] Natl Canc Ctr, Res Inst, Tokyo, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Pembrolizumab; pharmacokinetics; Elderly;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP11.03-08
引用
收藏
页码：S622 / S622
页数：1
相关论文
共 50 条
  • [1] Stage IV non-small cell lung cancer patients aged 75 years and older
    Tamura, T.
    Kurishima, K.
    Watanabe, H.
    Nakazawa, K.
    Ishikawa, H.
    Satoh, H.
    Hizawa, N.
    EUROPEAN GERIATRIC MEDICINE, 2015, 6 (01) : 31 - 35
  • [2] Pembrolizumab for the treatment of non-small cell lung cancer
    Muller, Mirte
    Schouten, Robert D.
    De Gooijer, Cornedine J.
    Baas, Paul
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (05) : 399 - 409
  • [3] Pembrolizumab for the treatment of non-small cell lung cancer
    Lim, Sung Hee
    Sun, Jong-Mu
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (03) : 397 - 406
  • [4] Surgery of Stage I Non-Small Cell Lung Cancer in Patients Aged 70 Years or Older
    Kawamata, O.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S1013 - S1013
  • [5] Radiotherapy for non-small cell lung cancer in patients aged 75 and over: safety, effectiveness and possible impact on survival
    Lonardi, F
    Coeli, M
    Pavanato, G
    Adami, F
    Gioga, G
    Campostrini, F
    LUNG CANCER, 2000, 28 (01) : 43 - 50
  • [6] Immunotherapy or Chemoimmunotherapy in Older Adults With Advanced Non-Small Cell Lung Cancer
    Tsukita, Yoko
    Tozuka, Takehiro
    Kushiro, Kohei
    Hosokawa, Shinobu
    Sumi, Toshiyuki
    Uematsu, Mao
    Honjo, Osamu
    Yamaguchi, Ou
    Asao, Tetsuhiko
    Sugisaka, Jun
    Saito, Go
    Shiihara, Jun
    Morita, Ryo
    Katakura, Seigo
    Yasuda, Takehiro
    Hisakane, Kakeru
    Miyauchi, Eisaku
    Morita, Satoshi
    Kobayashi, Kunihiko
    Asahina, Hajime
    JAMA ONCOLOGY, 2024, 10 (04) : 439 - 447
  • [7] Stereotactic Body Radiotherapy in Patients With Stage I Non-Small-Cell Lung Cancer Aged 75 Years and Older: Retrospective Results From a Multicenter Consortium
    Samuels, Michael A.
    Kandula, Shravan
    Koru-Sengul, Tulay
    Bogart, Jeffrey A.
    Salama, Joseph K.
    Aridgides, Paul D.
    Gajra, Ajeet
    Lilenbaum, Rogerio C.
    CLINICAL LUNG CANCER, 2013, 14 (04) : 446 - 451
  • [8] Spotlight on pembrolizumab in non-small cell lung cancer: the evidence to date
    Vachhani, Pankit
    Chen, Hongbin
    ONCOTARGETS AND THERAPY, 2016, 9 : 5855 - 5866
  • [9] The role of pembrolizumab in the treatment of advanced non-small cell lung cancer
    Santabarbara, Giuseppe
    Maione, Paolo
    Rossi, Antonio
    Palazzolo, Giovanni
    Gridelli, Cesare
    ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (11)
  • [10] Stage I Non-small Cell Lung Cancer (NSCLC) in Patients Aged 75 Years and Older Does Age Determine Survival After Radical Treatment?
    Palma, David A.
    Tyldesley, Scott
    Sheehan, Finbarr
    Mohamed, Islam G.
    Smith, Sally
    Wai, Elaine
    Murray, Nevin
    Senan, Suresh
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (06) : 818 - 824
12345